These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18086849)

  • 1. Antimycobacterial Activity and Mechanism of Action of NAS-91.
    Gratraud P; Surolia N; Besra GS; Surolia A; Kremer L
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1162-6. PubMed ID: 18086849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.
    Phetsuksiri B; Jackson M; Scherman H; McNeil M; Besra GS; Baulard AR; Slayden RA; DeBarber AE; Barry CE; Baird MS; Crick DC; Brennan PJ
    J Biol Chem; 2003 Dec; 278(52):53123-30. PubMed ID: 14559907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636.
    Bhowruth V; Brown AK; Besra GS
    Microbiology (Reading); 2008 Jul; 154(Pt 7):1866-1875. PubMed ID: 18599816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-
    Rehberg N; Omeje E; Ebada SS; van Geelen L; Liu Z; Sureechatchayan P; Kassack MU; Ioerger TR; Proksch P; Kalscheuer R
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR
    Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract]   [Full Text] [Related]  

  • 7. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.
    Chiarelli LR; Mori M; Beretta G; Gelain A; Pini E; Sammartino JC; Stelitano G; Barlocco D; Costantino L; Lapillo M; Poli G; Caligiuri I; Rizzolio F; Bellinzoni M; Tuccinardi T; Villa S; Meneghetti F
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):823-828. PubMed ID: 30889995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors.
    Duan X; Xiang X; Xie J
    FEMS Microbiol Lett; 2014 Nov; 360(2):87-99. PubMed ID: 25227413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of n-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG.
    Parrish NM; Ko CG; Hughes MA; Townsend CA; Dick JD
    J Antimicrob Chemother; 2004 Oct; 54(4):722-9. PubMed ID: 15355939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thia fatty acids as substrates and inhibitors of stearoyl-CoA desaturase.
    Høvik KE; Spydevold OS; Bremer J
    Biochim Biophys Acta; 1997 Nov; 1349(3):251-6. PubMed ID: 9434139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.
    Gratraud P; Huws E; Falkard B; Adjalley S; Fidock DA; Berry L; Jacobs WR; Baird MS; Vial H; Kremer L
    PLoS One; 2009 Sep; 4(9):e6889. PubMed ID: 19707292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stearoyl-CoA desaturase activity in bovine cumulus cells protects the oocyte against saturated fatty acid stress.
    Aardema H; van Tol HTA; Wubbolts RW; Brouwers JFHM; Gadella BM; Roelen BAJ
    Biol Reprod; 2017 May; 96(5):982-992. PubMed ID: 28486699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
    Dover LG; Alahari A; Gratraud P; Gomes JM; Bhowruth V; Reynolds RC; Besra GS; Kremer L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1055-63. PubMed ID: 17220416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
    Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
    J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the stearoyl-CoA desaturase system in octadecenoate metabolism in the Morris hepatoma 7288C.
    Zoeller RA; Wood R
    Biochim Biophys Acta; 1985 Jun; 845(3):380-8. PubMed ID: 2860925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Oleic Acid in the Gut-Liver Axis: From Diet to the Regulation of Its Synthesis via Stearoyl-CoA Desaturase 1 (SCD1).
    Piccinin E; Cariello M; De Santis S; Ducheix S; Sabbà C; Ntambi JM; Moschetta A
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31554181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.